Remarkably, individuals carrying these receptor polymorphisms lack any discernable biological phenotype other than resistance to HIV infection or delayed progression to AIDS, which indicated the potential value of targeting entry through the CCR5 coreceptor as a viable pharmacological intervention.
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}